Coenzyme Q10 in Relieving Treatment-Related Fatigue in Women With Breast Cancer (CoQ10)
A Randomized Double-Blind Placebo-Controlled Study Of Oral Coenzyme Q10 To Relieve Self-Reported Cancer Treatment Related Fatigue In Breast Cancer Patients
Sponsor: National Cancer Institute (NCI)
Listed as NCT00096356, this PHASE1 trial focuses on Breast Cancer and Fatigue and remains completed. Sponsored by National Cancer Institute (NCI), it has been updated 12 times since 2004, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
12 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE1
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE1
-
Oct 2021 — Jul 2024 [monthly]
Completed PHASE1
-
Jan 2021 — Oct 2021 [monthly]
Completed PHASE1
▶ Show 7 earlier versions
-
Mar 2019 — Jan 2021 [monthly]
Completed PHASE1
-
Oct 2018 — Mar 2019 [monthly]
Completed PHASE1
Phase: NA → PHASE1
-
Jun 2018 — Oct 2018 [monthly]
Completed NA
-
Aug 2017 — Jun 2018 [monthly]
Completed NA
-
May 2017 — Aug 2017 [monthly]
Completed NA
Phase: PHASE3 → NA
-
Feb 2017 — May 2017 [monthly]
Completed PHASE3
-
Jan 2017 — Feb 2017 [monthly]
Completed PHASE3
First recorded
Aug 2004
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Cancer Institute (NCI)
- Wake Forest University Health Sciences
For direct contact, visit the study record on ClinicalTrials.gov .